Related Experiment Video
Updated: May 5, 2026
06:46
Collection of Alfalfa Root Exudates to Study the Impact of Di2-ethylhexyl Phthalate on Metabolite Production
Published on: June 2, 2023
2.4K
Toxicological characterization of phthalic Acid
Du Yeon Bang1, In Kyung Lee, Byung-Mu Lee
1Laboratory of Toxicology, College of Pharmacy, Sungkyunkwan University, Suwon 440-746, Korea.
Toxicological Research
|November 27, 2013
Summary
Phthalic acid (PA), a metabolite of phthalate esters (PAEs), exhibits toxicity including mutagenicity and developmental issues. PA can serve as a biomarker for human exposure to PAEs.
Area of Science:
- Environmental Toxicology
- Metabolomics
- Chemical Safety
Background:
- Phthalate esters (PAEs) are widely used in cosmetics and industrial products, raising concerns about human exposure.
- Exposure assessment often involves analyzing urinary metabolites of PAEs.
- Phthalic acid (PA) is the final common metabolic product of various PAEs.
Purpose of the Study:
- To evaluate the toxicity of phthalic acid (PA).
- To explore the potential of PA as a biomarker for combined exposure to different PAEs.
Main Methods:
- Review of existing in vitro and in vivo studies on PA toxicity.
- Analysis of PA as a common metabolite of PAEs.
- Assessment of PA's utility as a biomarker for PAE exposure.
Main Results:
- Phthalic acid (PA) demonstrates in vitro and in vivo toxicity, including mutagenicity, developmental toxicity, and reproductive toxicity.
- PA is identified as a potential biomarker for assessing human exposure to multiple PAEs.
Conclusions:
- Phthalic acid (PA) poses toxicological risks and is a viable biomarker for human exposure to phthalate esters (PAEs).
- Further research into PA toxicity and its biomarker potential is warranted for public health risk assessment.
More Related Videos
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
12.4K
09:33Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
Published on: March 21, 2018
9.3K
Related Concept Videos
01:23Toxicity Testing in Animals
222
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
222
01:26Toxic Reactions: Overview
4.3K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
4.3K
01:16IUPAC Nomenclature of Aldehydes
5.6K
Aldehydes are named based on the systematic nomenclature rules set by the IUPAC. For acyclic aldehydes, the longest carbon chain containing the aldehydic (–CHO) group is considered the parent chain. The aldehyde is named by replacing the last letter “e” in the hydrocarbon name with “al”. For instance, a simple, seven-carbon-membered acyclic aldehyde is called heptanal, derived from heptane. The carbon chain is numbered starting from the aldehydic carbon, although...
5.6K
01:24Drug Toxicity: Dose-Dependent Reactions
245
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
245
01:21Toxicokinetics: Overview
330
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
330
01:36Types of Toxins
3.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.7K